Who owns EDESA BIOTECH INC COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Edesa Biotech with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Edesa Biotech stock

Who bought or sold EDESA BIOTECH INC COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Rubric Capital Management 688k $3.6M 0% Mar 2026
 View chart
Stonepine Capital Management 688k $976k 0% Dec 2025
 View chart
Velan Capital Investment Management 688k $976k 0% Dec 2025
 View chart
Perceptive Advisors 563k $2.9M 100% Mar 2026
 View chart
Jane Street 116k $605k 100% Mar 2026
 View chart
Vanguard Capital Management 86k $450k 100% Mar 2026
 View chart
Geode Capital Management 77k $403k 66% Mar 2026
 View chart
Diadema Partners 54k $77k 100% Dec 2025
 View chart
Vanguard Fiduciary Trust 38k $201k 100% Mar 2026
 View chart
Vanguard Group 38k $55k -17% Dec 2025
 View chart
Commonwealth Equity Services 35k $183k 100% Mar 2026
 View chart
Scientech Research 31k $160k 100% Mar 2026
 View chart
BlackRock 28k $145k 100% Mar 2026
 View chart
Schonfeld Strategic Advisors 20k $103k 100% Mar 2026
 View chart
State Street Corporation 19k $27k 100% Dec 2025
 View chart
Scotia Capital 16k $83k 100% Mar 2026
 View chart
SBI Securities 3.5k $18k 100% Mar 2026
 View chart
Tower Research Capital 2.6k $3.6k 100% Dec 2025
 View chart
UBS Group 2.3k $12k 72% Mar 2026
 View chart
Royal Bank of Canada 1.7k $9.0k -9% Mar 2026
 View chart
Citigroup 487.00 $2.5k 100% Mar 2026
 View chart
Vanguard Global Advisers 162.00 $847.000800 100% Mar 2026
 View chart
TD Waterhouse Canada 142.00 $792.005000 0% Mar 2026
 View chart
Global Retirement Partners 86.00 $121.999600 244% Dec 2025
 View chart
Banque Cantonale Vaudoise 3.00 $0 0% Mar 2026
 View chart
Danske Bank A/s 1.00 $5.000000 0% Mar 2026
 View chart
LRI Investments 1.00 $5.000000 0% Mar 2026
 View chart
Dogwood Wealth Management 1.00 $5.000000 0% Mar 2026
 View chart

Who sold out of Edesa Biotech?

Fund or Company Name Date Sold Shares Held Valued At
Nantahala Capital Management Dec 2025 625k $888k
DRW Holdings Dec 2025 134k $191k
Citadel Advisors Dec 2025 54k $78k
Renaissance Technologies Sep 2025 25k $62k
Susquehanna International Sep 2025 15k $36k
Persistent Asset Partners Dec 2025 12k $18k
Morgan Stanley Dec 2025 2.3k $3.3k
Barclays Sep 2025 6.00 $13.999800